Gómez-Pascual A, Naccache T, Xu J, Hooshmand K, Wretlind A, Gabrielli M, Lombardo MT, Shi L, Buckley NJ, Tijms BM, Vos SJB, Ten Kate M, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lleó A, Popp J, Martinez-Lage P, Streffer J, Barkhof F, Zetterberg H, Visser PJ, Lovestone S, Bertram L, Nevado-Holgado AJ, Gualerzi A, Picciolini S, Proitsi P, Verderio C, Botía JA, Legido-Quigley C. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.. COMPUTERS IN BIOLOGY AND MEDICINE. 2024; 176DOI:10.1016/j.compbiomed.2024.108588. PMID:38761503. IF:(Q/D).

Van Gils, V, Jansen, WJ, van der Flier, WM, Martinez-Lage, P, Hort, J, Ramakers, IHGB, Rouaud, O, Laakso, M, Engelborghs, S, Popp, J, Lleó, A, Wallin, A, Tsolaki, M, Teunissen, CE, Vandenberghe, R, Freund-Levi, Y, Frölich, L, Zetterberg, H, Streffer, J, Lovestone, S, Moonen, J, Van Harten, A, Veverová, K, Legdeur, N, Den Braber, A, Damian, D, Hall, A, Bralten, J, Fanelli, G, Franke, B, Poelmans, G, Bulló, M, Jimenez-Murcia, S, Fernandez-Aranda, F, Salas-Salvadó, J, Dalsgaard, S, Visser, PJ, Vos, SJB. The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts. ALZHEIMERS & DEMENTIA. 2025; 21(10)DOI:10.1002/alz.70804. PMID:41165072. IF:11.100(Q1/1D).

Jacobs, T, Brien, CO, Figueredo, L, Gogola, A, Gaggi, NL, Hurwitz, B, Pirraglia, E, Herzog, S, Ramos-Cejudo, J, Shepherd, TM, Palta, P, Fortea, J, Wisniewski, TM, Betensky, RA, Lopresti, B, Mielke, MM, Convit, A, Osorio, RS. Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2025; 21(10)DOI:10.1002/alz.70765. PMID:41074913. IF:11.100(Q1/1D).

Oomens, JE, van Gils, V, Vos, SJB, Freeze, WM, Maserejian, NN, Curiale, G, Gillis, C, Boada, M, van der Flier, WM, Hort, J, Johnson, SC, Lleo, A, Ramakers, IH, Rodrigue, KM, Sanchez-Juan, P, Sarazin, M, Scarmeas, N, Zetterberg, H, Alcolea, D, Barkhof, F, Blennow, K, Bottlaender, M, den Braber, A, Cerman, J, Drake-Perez, M, Fortea, J, Handels, R, Ingala, S, Jimenez-Bonilla, JF, Karavasilis, S, Lagarde, J, Legdeur, N, Lorenzini, L, Marquie, M, Moonen, JEF, Olivieri, P, Orellana, A, Ossenkoppele, R, Rivera-Rivera, LA, Rodriguez-Rodriguez, E, Laza, AR, Teunissen, CE, Tijms, BM, Velonakis, G, Verhey, FRJ, Visser, PJ, Jansen, WJ. Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study. JAMA Network Open. 2025; 8(1)DOI:10.1001/jamanetworkopen.2024.55571. PMID:39841474. IF:9.700(Q1/1D).